KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Share-based Compensation (2016 - 2025)

Pacific Biosciences Of California has reported Share-based Compensation over the past 16 years, most recently at $9.6 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $9.6 million for Q4 2025, down 40.2% from a year ago — trailing twelve months through Dec 2025 was $41.7 million (down 41.34% YoY), and the annual figure for FY2025 was $41.7 million, down 41.34%.
  • Share-based Compensation for Q4 2025 was $9.6 million at Pacific Biosciences Of California, down from $11.0 million in the prior quarter.
  • Over the last five years, Share-based Compensation for PACB hit a ceiling of $22.7 million in Q1 2022 and a floor of $7.5 million in Q3 2022.
  • Median Share-based Compensation over the past 5 years was $17.6 million (2023), compared with a mean of $15.8 million.
  • Biggest five-year swings in Share-based Compensation: surged 388.71% in 2021 and later plummeted 60.22% in 2022.
  • Pacific Biosciences Of California's Share-based Compensation stood at $18.9 million in 2021, then decreased by 5.19% to $18.0 million in 2022, then dropped by 7.64% to $16.6 million in 2023, then decreased by 3.32% to $16.0 million in 2024, then plummeted by 40.2% to $9.6 million in 2025.
  • The last three reported values for Share-based Compensation were $9.6 million (Q4 2025), $11.0 million (Q3 2025), and $11.9 million (Q2 2025) per Business Quant data.